Cargando…
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Autores principales: | Conway, B, Barrieshee, A, Tossonian, HK, Wight, K, Jassemi, S, Tong, M, Knight, E, Gallagher, L, Duncan, F, DeVlaming, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The International AIDS Society
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112981/ http://dx.doi.org/10.1186/1758-2652-13-S4-P199 |
Ejemplares similares
-
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
por: Tossonian, HK, et al.
Publicado: (2010) -
Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020) -
Managing HCV infection: present and future
por: Rockstroh, Jürgen K
Publicado: (2014) -
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014) -
Low reduction of HCV-RNA level at week 4 in HIV-1 infected patients with acute HCV Infection
por: Vincent, A, et al.
Publicado: (2012)